Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.

Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.

Here we report a unique situation in which an early and synchronized Epstein-Barr virus (EBV) reactivation was induced by a 6-day course of treatment with a humanized CD3-specific monoclonal antibody in patients with recent onset of type 1 diabetes. The virologic and immunologic analysis demonstrate...

Bibliografski detalji
Glavni autori:	Keymeulen, B, Candon, S, Fafi-Kremer, S, Ziegler, A, Leruez-Ville, M, Mathieu, C, Vandemeulebroucke, E, Walter, M, Crenier, L, Thervet, E, Legendre, C, Pierard, D, Hale, G, Waldmann, H, Bach, J, Seigneurin, J, Pipeleers, D, Chatenoud, L
Format:	Journal article
Jezik:	English
Izdano:	2010

Slični predmeti

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
od: Keymeulen, B, i dr.
Izdano: (2005)

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.
od: Keymeulen, B, i dr.
Izdano: (2010)

Infection with Epstein-Barr virus.
od: Warrell, D, i dr.
Izdano: (1978)

Infection with Epstein-Barr virus.
od: Warrell, D, i dr.
Izdano: (1978)

The epstein-Barr virus and the pathogenesis of lymphoma
od: Vockerodt, M., i dr.
Izdano: (2015)

Epstein-barr virus specific immunogen
od: Seow, Heng Fong, i dr.
Izdano: (2011)

Vaccination against the Epstein-Barr virus
od: Rühl, J, i dr.
Izdano: (2020)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
od: Hale, G, i dr.
Izdano: (1998)

Epstein-Barr virus associated diseases: an update
od: Pathmanathan, R.
Izdano: (1993)

Atomic structure of the Epstein-Barr virus portal
od: Machón, C, i dr.
Izdano: (2019)

Epstein-Barr Virus associated gastric carcinoma
od: Oh, H, i dr.
Izdano: (2007)

Epstein-Barr virus-negative diffuse large B-cell post-transplant lymphoma in an Epstein-Barr virus-positive recipient
od: Lee, C, i dr.
Izdano: (2021)

Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patients.
od: Alkemade, G, i dr.
Izdano: (2011)

Epstein-barr virus infection in carcinoma of the salivary gland
od: Raab-Traub, N., i dr.
Izdano: (1996)

Detection of epstein - barr virus (EBV) in nasopharyngeal cancer.
od: Seow, Heng Fong
Izdano: (2007)

Detection of epstein-barr virus in lower gastrointestinal tract lymphomas
od: Yunos, Asmah M., i dr.
Izdano: (2006)

Epstein–Barr virus, the germinal centre and the development of Hodgkin’s lymphoma
od: Mohamed, G., i dr.
Izdano: (2014)

Investigating mechanisms of Epstein-Barr virus reactivation in epithelial cells
od: Zentelis, S
Izdano: (2018)

Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma.
od: Herath, C, i dr.
Izdano: (2008)

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.
od: Wallace, L, i dr.
Izdano: (1981)

Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes.
od: Hale, G, i dr.
Izdano: (2010)

Epstein Barr virus latent membrane protein 1 in Hodgkin lymphoma
od: Lee, L.K., i dr.
Izdano: (2010)

Epstein-Barr viral latent and early antigen serology in nasopharyngeal carcinoma
od: Tan, Timothy Ter Ming.
Izdano: (2008)

Cloning and expression of epstein-barr viral antigens for the diagnosis of nasopharygeal carcinoma
od: He, Yan Xin.
Izdano: (2009)

Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda
od: Carpenter, L, i dr.
Izdano: (2008)

Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.
od: Carpenter, L, i dr.
Izdano: (2008)

Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.
od: Hill, A, i dr.
Izdano: (1995)

Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases
od: Abbott, RJ, i dr.
Izdano: (2017)

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
od: Chakrabarti, S, i dr.
Izdano: (2003)

Frequency of antigens expression and epstein-barr virus on diffuse large b-cell lymphoma
od: Lee, K.K., i dr.
Izdano: (2007)

Modulation of immunogenicity and Epstein-Barr virus gene expression in lymphomas with small-molecule inhibitors
od: Cheuk, Fabian Jia Jun
Izdano: (2023)

Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development?
od: Disanto, G, i dr.
Izdano: (2011)

Hubungan antara infeksi epstein-barr virus (EBV) dengan terjadinya karsinoma sinonasal
od: , SANTOSO, Olivia Desiana, i dr.
Izdano: (2010)

Visualising antigen-specific T-cells during primary and persistent infection with Epstein-Barr virus
od: Tan, L, i dr.
Izdano: (1999)

Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.
od: Holder, B, i dr.
Izdano: (2010)

Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector.
od: White, R, i dr.
Izdano: (2002)

Successful outcome of Epstein-Barr virus encephalitis managed with bilateral craniectomy, corticosteroids and aciclovir.
od: Hayton, E, i dr.
Izdano: (2012)

PENENTUAN TIPE VIRUS EPSTEIN-BARR DALAM BIOPSI JARINGAN NASOFARING PENDERITA NON KARSINOMA NASOFARING DENGAN POLYMERASE CHAIN REACTION (TYPING OF EPSTEIN-BARR VIRUS BY POLYMERASE CHAIN REACTION IN NASOPHARYNGEAL TISSUE
od: Perpustakaan UGM, i-lib
Izdano: (2000)

Clonal proliferations of cells infected with Epstein–Barr virus in preinvasive lesions related to nasopharyngeal carcinoma
od: Pathmanathan, Rajadurai, i dr.
Izdano: (1995)

Novel Epstein-Barr virus immunoglobulin G–based approach for the specific detection of nasopharyngeal carcinoma.
od: Abdulamir, Ahmed Sahib, i dr.
Izdano: (2010)